Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension of Beraprost Sodium Modified Release in PAH
NCT00990314Phase 2Completed
- Sponsor
- Lung Biotechnology PBC
- Start
- Nov 2009
- Primary completion
- Nov 2013
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 2 trial of beraprost in pulmonary arterial hypertension (PAH), sponsored by Lung Biotechnology PBC. Started Nov 2009; status: completed.
02
Drugs
beraprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00990314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00990314.